Delivery Order SPE2DB20D1109-SPE2DB24FN41J
Award Date
1/11/24
Potential Completion Date
1/12/24
Potential Value
$23K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $29,736.89 delivery order contract is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 11, 2024. This award is not associated with a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products. The award, valued at $17,908.87, is a firm fixed-price delivery order with a completion date of February 13, 2024. The contract covers the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $32,532.29 Firm Fixed Price delivery order covers the supply of RINVOQ ER 30 MG TABLET 30S, a specialty pharmaceutical product. This award is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of a pharmaceutical product, RINVOQ ER 15 MG TABLET, to the Defense Logistics Agency (DLA). The contract, valued at $24,147.11, is a firm-fixed-price delivery order with an ultimate completion date of April 16, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $18,697.38 firm fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET. The order has an ultimate completion date of October 19, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
This federal contract award, valued at $24,205.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 1, 2024. The contract covers the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, as a major pharmaceutical distributor and...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $10,714.94 for the supply of RINVOQ ER 15 MG TABLET products. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, a major healthcare provider for the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,445.66 Firm Fixed Price delivery order contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has a period of performance through February 27, 2024 and does not utilize any set-aside designations, indicating it was awarded through full and open competition. Amerisourcebergen holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $12,143.49 for the supply of RINVOQ ER 30 MG TABLET UU 30S medical products. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Defense agency, on December 21, 2023, with an ultimate completion date of December 22, 2023. The contract is a Firm Fixed Price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $11,893.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of RINVOQ ER 30 MG TABLET medical supplies, with an ultimate completion date of January 11, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...